Flag of Mali

Mali

Destination photograph: Mali
Bamako (Mali) banner.jpg · Arensond · CC0, via Wikimedia Commons. Displayed at a reduced size; no image edits.

Mali travel health

Sources checked

Overview

Travel to Mali carries several routine and location‑specific health considerations: proof of yellow fever vaccination is required on entry, malaria transmission occurs across the country and requires chemoprophylaxis, the country lies in the African “meningitis belt” with seasonal risk, and access to timely, advanced medical care can be limited outside Bamako. Plan vaccinations well before departure, carry medicines and a travel medical kit, and ensure travel insurance covers medical evacuation.

Yellow fever — legal entry requirement and vaccine recommendation

Mali requires a valid international yellow fever vaccination certificate for arriving travellers aged 9 months and older; public‑health authorities also recommend vaccination for almost all travellers to Mali (CDC advises vaccination for travellers ≥9 months). Some guidance notes limited exceptions for travel confined strictly to parts of the Sahara; check whether your planned area is considered at risk. World Health Organization — IHR vaccination requirements • U.S. CDC — Mali travel page (yellow fever).

Routine and commonly recommended vaccines

Make sure routine immunizations are up to date (MMR, DTaP/Tdap, polio, varicella, influenza). Additional vaccines commonly recommended for Mali include hepatitis A (recommended for most travellers), hepatitis B (recommended for unvaccinated travellers of any age), and typhoid (recommended for most travellers). Travelers who have not completed their polio series should be vaccinated before travel; some authorities advise a single inactivated poliovirus vaccine booster for previously vaccinated adults. Discuss COVID‑19 vaccination status with your clinician per local eligibility. U.S. CDC — Vaccines & medicines for Mali.

Meningococcal disease

Mali lies within the African meningitis belt; risk is highest in the dry season (roughly December–June). Travelers to areas in the belt during the dry season, long‑term travellers, and those who will have close contact with local communities should consider meningococcal vaccination (quadrivalent ACWY or newer pentavalent products where available). National reactive vaccination campaigns may occur during outbreaks; check whether your itinerary overlaps high‑risk districts. U.S. CDC — Meningococcal advice for Mali • World Health Organization — meningitis.

Rabies

Dog‑mediated rabies is endemic in Mali and dog bites are a common exposure. Post‑exposure prophylaxis (PEP) including rabies vaccine and immunoglobulin may be limited outside major centres. Consider rabies pre‑exposure vaccination if you will have occupational or prolonged outdoor or animal contact, or if timely access to PEP is uncertain. If bitten or scratched, wash the wound immediately and seek care urgently. U.S. CDC — Rabies • U.S. CDC — Rabies country risk & PEP availability.

Other health risks

Beyond vaccines, travellers should plan for protection from mosquito bites, food‑ and water‑borne illness, and the practical limits of local healthcare and sanitary infrastructure.

Malaria

Malaria (predominantly Plasmodium falciparum) occurs throughout Mali year‑round. CDC recommends that travellers to Mali take prescription antimalarial medication; commonly used options include atovaquone‑proguanil, doxycycline, mefloquine or tafenoquine (choice depends on medical history and drug interactions). Strict mosquito‑bite prevention (bed nets, repellents, clothing) is also essential. Seek immediate medical attention for any fever during travel or up to 1 year after return. U.S. CDC — Malaria guidance for Mali.

Food, water and diarrhoeal disease (including cholera risk)

Acute diarrhoea is common. Practice safe food and water precautions (drink bottled/boiled water, avoid ice and uncooked produce, use safe vendors). Regional cholera transmission and multi‑country cholera activity have been reported in recent years; while routine short‑term travellers usually have low risk, outbreaks can raise local risk and strain health services. Consider oral rehydration plans and know where to get local care if severe diarrhoea or dehydration occurs. U.S. CDC — Food and water safety • World Health Organization — multi‑country cholera updates.

Poliovirus (vaccine‑derived detections)

Circulating vaccine‑derived poliovirus has been detected in Mali within recent years; public‑health authorities advise ensuring polio vaccination is up to date before travel. Adults who completed childhood series may be offered a single inactivated poliovirus booster depending on circumstances; unvaccinated or incompletely vaccinated travellers should complete the series. U.S. CDC — Polio and travel • World Health Organization — IHR polio committee statement.

Vector-borne & zoonotic infections (dengue, chikungunya, leishmaniasis, others)

Aedes‑transmitted infections (dengue, chikungunya) and sand‑fly leishmaniasis occur in parts of Mali. Prevent mosquito and sand‑fly bites (repellents, nets, clothing). There are no widely‑recommended vaccines for dengue or chikungunya for most travellers; follow local advisories. U.S. CDC — Dengue and chikungunya info.

Access to care and travel logistics

Medical infrastructure is limited outside Bamako; many routine and emergency services, medicines and advanced care (intensive care, blood products, specialist surgery) can be unavailable or of variable quality. Evacuation to another country can be required for serious illness or injury. Check travel advisories, register with your embassy if appropriate, and confirm insurance covers medical evacuation. UK Foreign Travel Advice — healthcare in Mali • U.S. CDC — Mali country health notes.

Current health alerts

Only currently supported, destination‑specific developments are listed below.

Seasonal and reported meningitis activity (2026)

Mali is in the African meningitis belt and experiences seasonal increases in meningococcal disease during the dry season (roughly December–June). Regional surveillance reports and recent 2026 bulletins have documented cases in Mali; authorities may run reactive vaccination campaigns in affected districts. Travelers to at‑risk areas in the dry season should discuss meningococcal vaccination with their clinician. World Health Organization — meningitis facts & control • European Centre for Disease Prevention and Control — week 42 report (Mali cases).

Poliovirus detections and vaccination responses

Poliovirus (circulating vaccine‑derived strains) has been detected in Mali within recent years and remains a programmatic concern; WHO polio emergency committee statements note recent detections in the region. Ensure polio vaccination is current and follow national guidance for travellers and for children. World Health Organization — polio IHR committee (Aug 2026) • U.S. CDC — polio & travel advice.

Regional cholera activity (context)

WHO and regional surveillance have reported heightened cholera and acute watery diarrhoea activity across parts of Africa in 2025–2026; while not all countries report simultaneous outbreaks, local cholera transmission can occur and rapidly overwhelm services. Travelers should use strict water/food precautions and seek care promptly for severe diarrhoea. World Health Organization — cholera updates • ECDC — cholera surveillance.

Before you travel

Visit a travel‑medicine clinic 4–8 weeks before departure when possible to review vaccines and obtain prescriptions (antimalarials, antibiotics for traveller’s diarrhoea if appropriate, personal medical supplies). Carry documentation of required vaccinations (international certificate of vaccination for yellow fever), arrange comprehensive travel health insurance that includes medical evacuation, and plan how to access care at your destination.

Final note

This information summarizes published public‑health guidance. A travel‑health professional can advise on your itinerary, medical history and vaccination needs.

AI-generated landscape illustration inspired by Mali
AI-generated illustration inspired by Mali.

Mali: recent disease outbreaks

Sources checked

Recent reports

Measles — national surveillance and recent cluster reports

Regional epidemic intelligence described ongoing measles activity affecting Mali during late summer and early autumn 2026: Africa CDC reported a moderate-to-high risk and published counts (reported to Africa CDC on 20 September 2026) that included 506 suspected and 296 confirmed measles cases in Mali; this assessment was incorporated into the ECDC weekly report in October 2026. ECDC weekly report (3–9 Oct 2026). Mali’s national surveillance dashboard shows continuing low but detectable weekly case counts in October 2026 (for example small weekly increases reported in S34–S41), indicating that local transmission and heightened surveillance were ongoing at the time of review. Ministry of Health epidemiological dashboard (week S41, Oct 2026). Why it matters: measles spreads very easily among under‑immunized people; travelers should verify they are up to date with measles-containing vaccine before travel (see national and international vaccine guidance).

Dengue — localized increases reported, national surveillance advises vector precautions

Mali’s weekly surveillance bulletins and government communiqués during August–October 2026 noted recent increases in confirmed dengue cases in several reporting weeks and urged reinforced vigilance; the national dashboard recorded 9 confirmed dengue cases for epidemiological week 41 (5–11 Oct 2026) with a week-on-week increase noted. Ministry of Health dashboard (S41, Oct 2026); government press communiqués also referenced increases in dengue case counts in September–October 2026. ORTM government communiqué (18 Sep 2026). The Ministry has published routine dengue prevention guidance (eliminate standing water, use insect repellents and nets, seek care for persistent fever). Ministry of Health — vigilance and dengue prevention notices. Why it matters: dengue is transmitted by day‑biting Aedes mosquitoes (urban and peri‑urban); travelers should use personal mosquito‑avoidance measures and seek medical care for febrile illness because dengue can require urgent medical assessment.

Poliomyelitis (cVDPV2) — recent international review; no new Mali detections reported in 2026

The World Health Organization’s Polio IHR Emergency Committee statement (25 August 2026) and routine polio surveillance updates discuss ongoing global responses to circulating vaccine‑derived poliovirus (cVDPV) events. That statement lists Mali in the context of past cVDPV2 detections but indicates Mali’s most recent known detection predated 2026 (the last detection reported in WHO summaries was in 2025); no new Mali cVDPV2 detections were reported in the committee statement dated 25 Aug 2026. WHO polio IHR Emergency Committee statement (25 Aug 2026). Why it matters: poliovirus risk is managed by ensuring routine polio vaccination. Travelers (especially those working in health or with children) should confirm poliovirus immunization according to national and WHO guidance; consult national public‑health guidance before travel.

Other signals: meningitis, yellow fever and routine threats

Routine surveillance items in Mali’s weekly dashboard include occasional single or small numbers of meningitis and mpox reports (for example one meningitis case reported in week 41, Oct 2026), but no large acute meningitis cluster or large cholera event in the reporting window was published by the national authorities during the review period. Ministry of Health dashboard (S41, Oct 2026). Yellow fever remains a recognized endemic threat in parts of the region; historical single confirmed yellow‑fever events in Mali were noted in WHO summaries for earlier periods, but no active large yellow fever outbreak in Mali was announced during the 90‑day window. Travelers should be aware of and comply with routine yellow fever vaccination rules (see entry requirements below). WHO WER reporting (Sep 2026).

Entry, screening or new outbreak‑related travel measures

No newly announced, outbreak‑specific entry or arrival screening measures for Mali were identified in official sources during the 90‑day reporting window. The longstanding requirement for proof of yellow fever vaccination for travelers to Mali remains in place and is reiterated in recent travel health guidance from national and foreign ministries; travelers should carry an International Certificate of Vaccination where required. CDC country travel information (updated guidance) and France – travel health advice for Mali (15 Sep 2026). Practical note: consult the Mali Ministry of Health and your embassy for entry and health requirements immediately before travel; policies can be changed at short notice.

This summary is a snapshot of public surveillance and official reports checked on 27 October 2026. Conditions can change rapidly; travelers should check the Mali Ministry of Health, WHO updates, and their national travel‑health advice for the latest outbreak notices and entry requirements before departure.